1 Laboratory of Cellular and Molecular Biology, Division of Basic Science,
National Cancer Institute, Bethesda, MD 20892-4255, USA
2 Cell Biology and Metabolism Branch, National Institute of Child Health and
Human Development, National Institutes of Health, Bethesda, MD 20892,
USA
* Author for correspondence (e-mail: samelson{at}helix.nih.gov )
Accepted 28 January 2002
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: Grb2, EGFR, SH3 domain, Endocytosis, GFP
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Grb2 consists of an SH2 domain flanked by two SH3 domains
(Lowenstein et al., 1992;
Rozakis-Adcock et al., 1992
).
The SH2 domain, by its interactions with phosphotyrosine residues in a
specific sequence context, mediates binding to a variety of activated
receptors and adaptor molecules. The SH3 domains of Grb2 bind proline-rich
sequences such as those found in the Ras guanine nucleotide exchange factor,
SOS (Chardin et al., 1993
;
Egan et al., 1993
;
Li et al., 1993
;
Rozakis-Adcock et al., 1993
).
Hence, Grb2 links ligand-activated receptors coupled to tyrosine kinases to
the distal signaling apparatus.
The EGFR has been extensively investigated over many years, and it serves
as an excellent model of a receptor that mediates such diverse cellular
phenomena as proliferation and differentiation
(Sorkin, 1998). The EGF ligand
induces dimerization of the receptor, which leads to activation of the protein
tyrosine kinase activity intrinsic to the receptor. Phosphorylation of
multiple tyrosine residues on the cytosolic domain of the receptor creates
binding sites for interaction with enzymes such as phospholipase C
1
[PLC
1 (Zhu et al.,
1992
)] and phosphatidylinositol 3-kinase [P13K
(Hu et al., 1992
)], and the
adaptors Shc (Okabayashi et al.,
1994
; Soler et al.,
1994
) and Grb2 (Buday and
Downward, 1993
; Lowenstein et
al., 1992
; Okutani et al.,
1994
). Such interactions are critical to the induction of those
signaling events that the receptor regulates.
Attenuation of EGFR signals has also been extensively studied. One
mechanism for downregulation is EGFR internalization. It has been reported
that mutant EGF receptors that are defective in internalization lead to
ligand-induced transformation (Wells et
al., 1990), supporting the importance of receptor downregulation.
To date, the role for Grb2 in EGFR internalization has been controversial, and
biochemical and immunofluorescence microscopy studies have produced
conflicting results (Chang et al.,
1991
; Chang et al.,
1993
; Wang and Moran,
1996
). The exact function of Grb2 in EGF receptor dynamics remains
poorly understood.
In this study we made use of the GFP spectral variants, YFP and CFP
(Ellenberg et al., 1998;
Ellenberg et al., 1999
), which
we fused to Grb2 and EGFR, respectively. Because YFP and CFP are
distinguishable from each other based on the difference in their fluorescence
excitation and emission patterns, we were able to follow the spatio-temporal
relationship of these two chimeric molecules (Grb2-YFP and EGFR-CFP) in single
live cells using confocal microscopy. We show that Grb2-YFP binds EGFR-CFP in
an SH2-dependent fashion. Following activation, both internalize together in
large macropinocytic structures that are temporally, morphologically and
biochemically distinct from conventional transferrin-containing endocytic
structures. Expression of Grb2-YFP containing mutations in either SH3 domain
did not block recruitment of Grb2 to the plasma membrane upon EGF stimulation
but impeded the subsequent inward translocation of the macropinocytic
structures enriched in Grb2 and EGFR. These results demonstrate a role of Grb2
in events associated with EGFR internalization in activated cells.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cells
Both A431 cells and COS-7 cells were grown in complete DMEM medium (DMEM
containing 10% fetal bovine serum (FBS), 2 mM glutamine, and 50 µg/ml
gentamicin).
Constructs
Both YFP and CFP (human codon-optimized W7) GFP variants were described
previously (Ellenberg et al.,
1998; Ellenberg et al.,
1999
). pYFP-N1 and pCFP-N1 vectors have the same backbone as
pEGFP-N1, except the EGFP sequence is replaced by the YFP and the CFP
sequence, respectively. The construct encoding the C-terminal domain of
AP180-C (Ford et al., 2001
)
was a kind gift of H. McMahon, MRC Laboratory of Molecular Biology,
Cambridge.
Plasmid constructions were conducted as follows: (1) pYFP/Grb2 (encoding wild-type Grb2-YFP). The BamHI-EcoRI fragment from the pGEX-3X plasmid containing human Grb2 was ligated to the BamHI-EcoRI fragment of pBluescript II KS (pBKS/Grb2). The AflIII-NspI fragment was removed from pBKS/Grb2, and then the vector was religated using the oligos 5' TTT CCC CGC AAT TAT GTC ACC CCC GTG AAC CGG AAC GTC GGT GGA GGT GGA CCG GTA 3' and 5' CAT GTA CCG GTC CAC CTC CAC CGA CGT TCC GGT TCA CGG GGG TGA CAT AAT TGC GGG GAA ACA TG 3' (pBKS/Grb2-4G). The SacI-AgeI fragment from pBKS/Grb24G was ligated to SacI/AgeI-digested pYFP-N1 vector (pYFP/Grb2).
(2) pYFP/R86K Grb2 (encoding SH2m-YFP). The BamHI-BglII fragment from the pGEX-3X plasmid containing human Grb2 with a R86K mutation was ligated to the BglII-digested pYFP/Grb2 (pYFP/R86K Grb2).
(3) pYFP/P49L Grb2 (encoding NSH3m-YFP). The BamHI-BglII fragment from the pGEX-3X plasmid containing human Grb2 with a P49L mutation was ligated to the BglII-digested pYFP/Grb2 (pYFP/P49L Grb2).
(4) pYFP/P49L, G203R Grb2 (encoding NCSH3m-YFP). A PCR product with the G203R mutation was created using pGEX-3X plasmid containing G203R Grb2 as a template with the oligos 5' TAT CAC AGA TCT ACA TCT 3' and 5' GGC GAC CGG TCC ACC TCC ACC GAC GTT CCG GTT CAC GGG 3'. Then, the BglII/AgeI-digested PCR product was ligated to the BglII-AgeI fragment of pYFP/P49L Grb2 (pYFP/P49L, G203R Grb2). The sequence of this construct was verified using the Sequenase II DNA sequencing kit.
(5) pYFP/G203R Grb2 (encoding CSH3m-YFP). The NheI-BglII fragment of pYFP/P49L, G203R Grb2 was replaced with XbaI-BglII fragment from pYFP/Grb2 to remove the P49L mutation (pYFP/G203R Grb2).
(6) pCFP/EGFR (encoding EGFR-CFP). The XhoI fragment from LTR2-EGFR (kindly provided by J. Rubin, Laboratory of Cellular and Molecular Biology, NCI, NIH) containing the entire human EGFR was ligated to XhoI-digested pBluescript II KS (pBKS-EGFR). The HindIII-KpnI fragment from pBKS/EGFR was subcloned into HindIII/KpnI-digested pCFP-N1 vector (pCFP/EGFR Hind-Kpn). pCFP/EGFR Hind-Kpn was digested with SalI, filled in with Klenow fragment, and then religated (pCFP/Sal BL). The junction between the EGFR and CFP was created by PCR using pBKS-EGFR as a template together with the oligos 5' GCC ACC CAT ATG TAC CAT C 3' and 5' GGC CCG CGG TGC TCC AAT AAA TTC ACT G 3'. The AccI/SacII digested PCR product was ligated to the AccI-SacII fragment of pCFP/Sal BL (pCFP/EGFR).
Transfection
COS-7 cells were transfected by electroporation using 10 µg of pCFP/EGFR
and 5 µg of either pYFP/Grb2 or pYFP/mutant Grb2. 10 µg of either
pYFP/Grb2 or pYFP/mutant was transfected into A431 cells. Electoroporation was
performed at 250 V and 500 µF for COS-7 cells and at 310 V and 960 µF
for A431 cells with a Gene Pulser (Bio-Rad).
Confocal time-lapse imaging
Transfected cells were grown in coverglass chambers (LabTek) for 24 hours
in complete DMEM medium. The medium was then replaced with DMEM medium free of
phenol red and supplemented with 0.5% FBS, 2 mM glutamine and 50 µg/mg
gentamicin. After a further 16 hours of incubation, the cells were subjected
to time-lapse imaging.
For dual color GFP time-lapse imaging
(Ellenberg et al., 1998;
Ellenberg et al., 1999
), the
chambers were mounted on a temperature-controlled stage of a confocal
microscope (model LSM 410; Carl Zeiss) using the 63x objective (NA 1.4).
To image YFP, the 488 nm laser line (Omnichrome Series 43, Omnichrome Inc.)
was used with a standard dual FT 488/568 dichroic and a BP 515-560 (both Carl
Zeiss). To image CFP, the 413 nm Kr laser line (Coherent Enterprise II,
Coherent Inc.) was used in conjunction with a FT440 dichroic and a LP 460
emission filter (both Chroma Technology Corp.). Images of Grb2-YFP and
EGFR-CFP were captured just before addition of EGF (100 ng/ml for COS-7 and
500 ng/ml for A431, Calbiochem) directly to the chamber, and subsequent images
were taken every 30 seconds. Time-lapse sequence was recorded using a macro
program that allows autofocusing on the coverslip surface in the reflection
mode before capturing confocal fluorescence images.
Immunofluorescence staining of fixed cells
COS-7 cells were grown in coverglass chambers (LabTek) for 24 hours in
complete DMEM medium, which was then replaced with DMEM medium free of phenol
red supplemented with 0.5% FBS, 2 mM glutamine, and 50 µg/mg gentamicin.
After a further 16 hours incubation, EGF stimulation (100 ng/ml) was carried
out. Cells were then fixed in 3.7% paraformaldehyde in PBS for 30 minutes at
room temperature, washed (three times) in PBS containing 10% fetal bovine
serum (PBS/FBS), permeabilized using 0.1% Triton X-100 in PBS for 4 minutes at
room temperature, washed (three times), and incubated for 45 minutes in
PBS/FBS for preblocking. Cells were then incubated with anti-EGFR antibody in
PBS/FBS for 45 minutes at room temperature, washed, and incubated with
TRITC-labeled goat anti-mouse IgG antibody for 45 minutes, followed by washing
with PBS (three times). Stained samples were viewed using the 568-nm laser
line of a confocal laser scanning microscope using the 63x objective (NA
1.4).
Uptake assays
Transfected cells were incubated as described above in complete DMEM
medium, then in DMEM medium containing 0.5% FBS before assays. Cells were
incubated with transferrin-TRITC conjugate (50 µg/ml) (Molecular Probes) at
37°C for 40 minutes. Following three washes with phenol-red-free DMEM
medium containing 0.5% FBS, uptake of transferrin-TRITC was monitored in the
absence of EGF by time-lapse imaging. For uptake assays in the presence of
EGF, cells were incubated with transferrin-TRITC at 4°C for 40 minutes,
washed with ice-cold phenol-red-free DMEM containing 0.5% FBS, then incubated
with the same medium containing EGF (100 ng/ml) at 37°C. Incorporation of
transferrin-TRITC was monitored using confocal microscopy.
Sequestration assay
Internalization of either EGFR or TfnR was measured by avidin
inaccessibility (Vieira et al.,
1996) using a FACScan (Becton-Dickinson). Transfected COS-7 cells
were dissociated for 5 minutes at 37°C in PBS containing 5 mM EDTA, washed
and resuspended at 2x106 cells/ml in DMEM containing 0.5% BSA
and 25 mM Hepes (buffer A) at 0°C. Either B-EGF or B-Tfn was added to a
final concentration of 40 ng/ml or 10 µg/ml, respectively, and incubation
was continued for 15 minutes at 0°C. Unbound B-EGF or B-Tfn was removed by
washing with buffer A at 0°C. Cells were split into aliquots
(2x105 cells), incubated at 37°C for the indicated times
and then returned to icy water. 5 µl of streptavidin-Quantum Red was added
to 20 µl aliquots of cells resuspended in PBS containing 0.1% BSA and 0.1%
sodium azide (staining buffer). Following washing with staining buffer, data
was collected on a FACScan and analyzed using CELLQuest software
(Becton-Dickinson). Avidin inaccessibility (AI) was calculated as in the
equation,
![]() |
To determine the effect of EGF stimulation on Tfn uptake, avidin inaccessibility was similarly measured except that cells were incubated with B-Tfn (10 µg/ml) plus EGF (100 ng/ml). Nonspecific binding of either B-EGF or B-Tfn was determined in the presence of at least 100-fold molar excess unlabeled EGF or Tfn, respectively.
Immunoprecipitation assays
Unstimulated or EGF-stimulated transfected cells were lysed in Brij/Octyl
glucoside lysis buffer (1% Brij 97, 0.5% octyl glucoside, 150 mM NaCl, 5 mM
EDTA) on ice for 30 minutes. After centrifugation, the supernatant was
collected. Lysates were subjected to immunoprecipitation with an anti-GFP
antibody. Anti-GFP immunoprecipitates were then analyzed by SDS-PAGE and
western blotting using relevant antibodies
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In addition to preparing a chimera of wild-type Grb2 with YFP (Grb2-YFP,
Fig. 1A), we also added YFP to
the C-terminus of several Grb2 mutants (SH2m-, NSH3m-, CSH3m- and NCSH3m-YFP)
in order to investigate the contribution of the individual SH2 and SH3 domains
to the dynamics of Grb2. The R86K (arginine 86 to lysine) mutation in the SH2
domain is known to disrupt SH2 domain-phosphotyrosine interactions
(Clark et al., 1992). The
mutations P49L (proline 49 to leucine) and G203R (glycine 203 to arginine) are
in the N- and C-terminal SH3 domains, respectively. These mutants of Grb2
correspond to loss-of-function phenotypes in Caenorhabditis elegans
(Clark et al., 1992
) and are
known to block SH3-mediated interactions
(Egan et al., 1993
). For all
Grb2-YFP fusion proteins, four glycine residues were placed as a linker
between Grb2 and YFP to increase flexibility in that region.
|
We fused CFP to the EGFR C-terminus (EGFR-CFP,
Fig. 1B). A similar chimera,
where EGFR was tagged with the enhanced GFP (EGFP) at the C-terminus, was
already reported to behave like endogenous EGFR, exhibiting such expected
function as tyrosine phosphorylation upon EGF stimulation, association with
Shc and endocytosis via an interaction with AP-2
(Carter and Sorkin, 1998). All
GFP chimeric molecules in this study demonstrated the expected apparent
molecular weight by western blotting using an anti-GFP antibody (52 kDa for
Grb2-YFP and 207 kDa for EGFR-CFP), and were detected specifically with
antibodies directed against Grb2 or EGFR
(Fig. 1C,D).
Wild-type Grb2 tagged with YFP functions similarly to Grb2
Grb2 is known to associate with a variety of receptors upon receptor
ligation via interactions of its SH2 domain and phosphotyrosine residues. In
addition, the SH3 domains of Grb2 mediate Grb2 binding to critical signaling
molecules such as SOS (Chardin et al.,
1993; Egan et al.,
1993
; Li et al.,
1993
; Rozakis-Adcock et al.,
1993
), Cbl (Buday et al.,
1996
; Hanazono et al.,
1996
; Meisner et al.,
1995
), WASP (Cory et al.,
1996
; She et al.,
1997
), MEKK1 (Pomerance et
al., 1998
) and dynamin (Ando et
al., 1994
; Barylko et al.,
1998
; Gout et al.,
1993
; Herskovits et al.,
1993
; Lin et al.,
1997
; Vidal et al.,
1998
; Wang and Moran,
1996
).
To test whether Grb2-YFP behaves like Grb2, we performed immunoprecipitation assays using cell lysates from A431 cells transfected with wild-type Grb2-YFP. EGFR was coimmunoprecipitated with Grb2-YFP upon EGF stimulation (Fig. 1E), suggesting that Grb2-YFP becomes inducibly bound to EGFR as does endogenous Grb2. Additionally, anti-GFP immunoprecipitates from A431 cells expressing wild-type Grb2-YFP (Fig. 1F, lane 2) contained SOS, Cbl and dynamin without EGF stimulation, showing the constitutive associations of Grb2-YFP with these critical molecules. Based on its binding specificity, Grb2-YFP behaves similarly to Grb2.
SH2-domain-dependent translocation of Grb2-YFP to the plasma
membrane
To demonstrate by imaging that EGF stimulation induces the redistribution
of Grb2 to the plasma membrane, we expressed Grb2-YFP, as well as Grb2
mutant-YFP fusion proteins in A431 cells. A431 human epidermoid cells were
used as they bear abundant EGFR (Gamou et
al., 1984; Haigler et al.,
1979
; Krupp et al.,
1982
). Grb2-YFP was diffusely cytosolic in the resting state
(Fig. 2A). Translocation
towards the cell periphery began immediately after EGF was added.
Redistribution of Grb2-YFP to the plasma membrane was completed within a
minute of EGF stimulation (Fig.
2B). Concurrently, the amount of Grb2-YFP in the cytoplasm
decreased 1 minute after EGF stimulation, leaving a central lucency. We also
tested whether an N-terminally tagged Grb2 construct, YFP-Grb2, redistributed
to the plasma membrane in the same fashion. YFP-Grb2 translocation upon EGF
stimulation was almost identical to C-terminally tagged Grb2 (data not shown),
indicating that the redistribution of the Grb2 chimeras with GFP can be
attributed to the Grb2 sequence itself. These observations support the
biochemical evidence for EGF-induced translocation of Grb2 from the cytosol to
the plasma membrane where Grb2-EGFR interactions occur. Note that a
significant amount of Grb2 accumulates in the nucleus after EGF stimulation as
previously reported (Romero et al.,
1998
).
|
We expressed SH2m-YFP in A431 cells to confirm that translocation to the membrane was dependent on the SH2 domain interactions with phosphorylated EGFR. As expected, no redistribution of SH2m-YFP was seen upon EGF stimulation (Fig. 2C,D), indicating that translocation of YFP-tagged Grb2 to the plasma membrane was dependent on an intact Grb2 SH2 domain. Grb2 SH3 domain mutants tagged with YFP (NSH3m-, CSH3m- and NCSH3m-YFP) translocated to the plasma membrane with similar kinetics to that of wild-type Grb2-YFP in response to EGF (Fig. 2F,H,J). Thus, EGF-induced redistribution of Grb2-YFP to the plasma membrane was not only SH2 domain dependent, but did not require intact SH3 domains.
EGFR-CFP recruits Grb2-YFP to the plasma membrane and is internalized
with Grb2-YFP
To address the spatio-temporal relationship between Grb2 and EGFR upon
receptor activation with EGF, we co-expressed both wild-type Grb2-YFP
(Grb2-YFP) and EGFR-CFP. To avoid any complication because of the large amount
of endogenous EGFR on A431 cells (1-2x106/cell)
(Gamou et al., 1984;
Haigler et al., 1979
;
Krupp et al., 1982
), Grb2-YFP
and EGFR-CFP were co-expressed in COS-7 cells, which have low levels of
endogenous EGFR. In unstimulated cells, EGFR-CFP localized both to the plasma
membrane and to punctate structures scattered in the periphery and the
perinuclear region, whereas Grb2-YFP was diffusely cytosolic
(Fig. 3, pre-EGF stimulation).
A significant pool of Grb2-YFP redistributed to the plasma membrane within a
minute of EGF stimulation (Fig.
3, 1 minute), where it co-localized with EGFR-CFP. Note also that
Grb2-YFP also accumulated transiently in the nucleus, as found in A431 cells.
EGF-induced redistribution of Grb2-YFP in COS-7 did not occur unless EGFR-CFP
was co-expressed (data not shown), which suggested that the phosphorylation of
endogenous EGFR was not sufficient to make translocation of Grb2-YFP
detectable in this context. Importantly, Grb2-YFP was not recruited to the
internal structures containing EGFR-CFP upon EGF stimulation
(Fig. 3, 1 minute and 4
minute). Given that redistribution of Grb2-YFP to the plasma membrane was
clearly observed upon EGF stimulation either in A431 cells expressing large
amounts of endogenous EGFR, or in COS-7 cells co-expressing EGFR-CFP, it
appears that recruitment of Grb2-YFP to the plasma membrane in EGF-stimulated
cells is mediated by EGFR.
|
Immediately following Grb2-YFP translocation to the plasma membrane upon EGF stimulation, the cells began to exhibit ruffling activity at their plasma membrane (Fig. 3). Spherical and sack-like structures reminiscent of macropinosomes that contained Grb2-YFP and EGFR-CFP then started to appear at and detach from the plasma membrane. The accompanying movie shows high resolution images and video sequences of these structures, which moved towards the perinuclear region over time with both Grb2-YFP and EGFR-CFP remaining associated (see http://jcs.biologists.org/supplemental ). The perinuclear pool of EGFR-CFP observed prior to activation remained distinct from the large macropincytotic structures containing Grb2-YFP and EGFR-CFP, indicating that only Grb2-YFP was recruited to and remained associated with membranes containing activated EGFR.
Grb2-YFP-containing structures that internalize in response to EGF
contain dynamin but not clathrin, transferrin or AP2
To further characterize the large spherical structures containing Grb2-YFP
and EGFR-CFP that arose off the plasma membrane during EGF stimulation, we
performed double-labeling experiments using antibodies to proteins known to
participate in clathrin-mediated receptor internalization, including clathrin,
AP2 and dynamin (Schmid et al.,
1998) (Fig. 4). We
also compared the distribution of the spherical structures to that of Tf,
which is internalized into the clathrin-mediated endocytic pathway
(Fig. 5A, top row). When we
stained cells expressing Grb2-YFP with antibodies to clathrin heavy chain
(CHC), which assembles with clathrin light chain to form clathrin lattices on
the cytosolic surfaces of membranes (Marsh
and McMahon, 1999
), very little, if any, labeling of the
Grb2-YFP-containing spherical structures was observed
(Fig. 4, CHC). Antibody
staining of the adaptor protein AP2, which helps recruit cargo into
clathrin-coated pits (Marsh and McMahon,
1999
), revealed that this protein also was not enriched on the
Grb2-YFP-containing structures (Fig.
4, AP2). However, significant labeling of the Grb2-YFP-containing
structures with dynamin antibodies was observed
(Fig. 4, Dynamin).
TRITC-Transferrin, used to monitor clathrin-mediated endocytosis, showed a
pattern of uptake that was similar to that observed in unstimulated cells and
that did not co-localize with Grb2-YFP
(Fig. 5A). Moreover, the rate
of uptake of biotinylated transferrin (Tfn) in the activated cells was
indistinguishable from unstimulated cells
(Fig. 5B). These data suggest
that EGF-induced, Grb2-YFP-containing structures are distinct from
conventional clathrin-derived endocytic intermediates, and internalize plasma
membrane receptors, such as EGFR, in a pathway that operates in parallel to
the clathrin-mediated uptake pathway.
|
|
Inhibition of clathrin-mediated uptake by AP-180 overexpression does
not prevent EGFR internalization in response to EGF stimulation of starved
cells
To rule out a role of clathrin in the uptake of EGFR-CFP in response to
EGF, we co-expressed EGFR-CFP and the C-terminal domain of AP180 in COS cells.
AP180 is an adaptor protein that plays an important role in clathrin-mediated
endocytosis (Ford et al.,
2001). When overexpressed in cells, it has been shown to block
clathrin-mediated uptake of proteins from the plasma membrane
(Ford et al., 2001
). To assess
the extent of inhibition of the clathrin-mediated pathway by AP180
overexpression, transfected cells were incubated with rhodamine-labeled
transferrin. As shown in Fig.
6, transferrin failed to localize to the perinuclear region in
cells overexpressing AP180. When serum-starved cells were stimulated with EGF,
EGFR-CFP still internalized into large macropinocytic structures in cells
overexpressing AP180. The data thus indicate that EGFR internalization into
macropinocytic structures in response to EGF after serum starvation is not
mediated by clathrin.
|
Grb2 SH3 domain mutants prevent inward translocation of endocytic
structures that have sequestered EGF receptors in EGF-stimulated cells
We next sought to clarify the role of Grb2 in the events associated with
the EGF-stimulated EGFR uptake pathway. We co-expressed EGFR-CFP in COS-7
cells with SH3 mutants of Grb2 to test whether disruption of the structural
integrity of Grb2 SH3 domains affected the dynamics of EGFR internalization.
Prior to EGF stimulation, cells expressing an NSH3 mutant of Grb2 tagged with
YFP (NSH3m-YFP) showed that the chimera was diffusely cytosolic, whereas
EGFR-CFP was localized on the plasma membrane and in perinuclear structures
(Fig. 7, 0'). Within 1
minute of EGF stimulation, NSH3m-YFP molecules translocated to the plasma
membrane (Fig. 7, 1'),
similar to that observed for Grb2-YFP molecules shown above. However, the
subsequent fate of NSH3m-YFP and EGFR-CFP at the plasma membrane was different
from that observed for wild-type Grb2-YFP and EGFR-CFP
(Fig. 7, 20', 30').
NSH3m-YFP and EGFR-CFP remained peripherally localized instead of moving into
the cytoplasm (Fig. 7). They
remained closely apposed to the plasma membrane for significant periods of
time after addition of EGF, with the large spherical structures containing
NSH3m-YFP and EGFR-CFP unable to translocate inwards. These structures were
relatively static and often appeared in confocal sections to be tethered by
thin membrane tubules with the plasma membrane
(Fig. 7, inset). A blockade of
the inward translocation of peripheral structures containing EGFR-CFP was
similarly observed in EGF-activated cells overexpressing either CSH3m- or
NCSH3m-YFP. Movie versions of the blockade induced by NSH3m-, CSH3m- or
NCSH3m-YFP can be found at
http://jcs.biologists.org/supplemental
.
|
The EGF-induced, spherical structures containing EGFR-CFP in NSH3m-YFP-expressing cells could be labeled with dynamin antibodies, but not with antibodies to CHC or AP2 (Fig. 8). Additionally, TRITC-Tfn that was taken up from the plasma membrane did not label these structures, but was found associated with other endocytic structures instead (Fig. 5A). Flow cytometric assays performed using biotinylated Tfn further revealed that the rate of internalization of Tfn was not affected in cells expressing the Grb2 SH3 domain mutants (Fig. 5B). These data indicate that over-expression of SH3 domain mutants of Grb2 has a profound effect on the inward movement of plasma membrane-derived structures containing EGFR without perturbing clathrin-mediated uptake of Tfn.
|
EGF receptors internalized in EGF-stimulated cells expressing Grb2
SH3 domain mutants are inaccessible to the cell exterior
To further investigate the nature of the inhibitory effect on
EGF-stimulated EGFR trafficking caused by expression of Grb2 SH3 domain
mutants, we asked whether the spherical structures containing EGFR-CFP that
localized near the plasma membrane under these conditions represented fully
budded membrane vesicles whose contents were inaccessible to the cell
exterior, or represented vesicles still continuous with the plasma membrane
whose contents were accessible to the extracellular space. To distinguish
between these possibilities, EGF-stimulated COS-7 cells expressing EGFR-CFP
and NSH3m-YFP were either permeabilized or left unpermeabilized following
fixation, and were then immunostained with an antibody directed against the
extracellular domain of EGFR. In permeabilized COS-7 cells, most of the
spherical structures associated with the plasma membrane were detected by the
antibody (Fig. 9B). Some of the
spherical structures appeared to be detached from the plasma membrane, but 3D
reconstruction based on a series of confocal images in the Z-axis showed that
they were always closely associated with the plasma membrane (data not shown).
By contrast, without permeabilization, these structures
(Fig. 9C, arrows) could not be
labeled with the antibody (Fig.
9D), indicating that EGFRs in them were not accessible to this
antibody. This suggested that, in the presence of Grb2 SH3 mutants, EGFR and
Grb2 are sequestered into domains of the plasma membrane that are no longer
exposed to the outside. Consistent with this, we found that biotinylated EGF
could be internalized into these cells (measured by avidin inaccessibility) at
a rate similar to the rate in cells expressing wild-type Grb2-YFP
(Fig. 9E). These results
indicate that, in cells expressing Grb2 SH3 domain mutants, EGF-stimulation
results in uptake of EGFR into endocytic structures that remain closely
associated with the plasma membrane and that are inaccessible to the
extracellular environment.
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
For the EGFR, which is known to interact with Grb2, early reports suggested
that Grb2 might not regulate EGFR internalization, since internalization of
EGFR mutants lacking the Grb2-binding domain still occurred but at a slower
rate than normal (Chang et al.,
1991; Chang et al.,
1993
). However, Wang and Moran showed that EGF-induced EGFR
endocytosis was blocked in MDCK cells following microinjection of Grb2
containing the G203R C-SH3 domain mutation
(Wang and Moran, 1996
),
suggesting that Grb2 functions in EGF-induced EGFR endocytosis. Further
support to this view was provided by Sorkin et al., who showed that in
EGF-stimulated cells EGFR-CFP and Grb2-YFP co-localize in endosomes and can
undergo fluorescence energy transfer (FRET), an indicator of protein-protein
interactions (Sorkin et al.,
2000
). However, the specific role Grb2 plays in EGF-stimulated
EGFR internalization (e.g. receptor sorting, vesicle budding/pinching or
vesicle transport) has remained unclear.
In the present study we clarify the role of Grb2 in EGFR internalization by
directly visualizing EGFR and Grb2 dynamics in EGF-stimulated cells expressing
wild-type or mutant SH2/SH3 domains of Grb2. Grb2-YFP redistributed to the
cell periphery immediately after EGF stimulation. This redistribution required
an intact Grb2 SH2 domain consistent with previous biochemical data
(Lowenstein et al., 1992).
Mutation of either or both Grb2 SH3 domains had no effect on the dynamics of
translocation to the plasma membrane. However, time-lapse confocal microscopy
revealed that the SH3 mutants prevented the stimulation-dependent inward
translocation of EGFR-containing endocytic structures that was observed in
wild-type Grb2-expressing cells. Therefore, the SH3 domains of Grb2 appear to
orchestrate the machinery necessary for translocating endocytic membranes
carrying EGFR from the periphery to the interior of the cell.
Several properties of the endocytic membranes carrying EGFR-CFP and
Grb2-YFP in EGF-stimulated cells suggested that they were distinct from
clathrin-derived endocytic structures. First, their appearance was coupled to
the translocation of Grb2-YFP to the plasma membrane and the subsequent
ruffling activity of these membranes, which often seemed to give rise directly
to the large, EGFR-CFP- and Grb2-YFP-containing endosomes. Second, the
surfaces of these endocytic membranes were depleted of molecules associated
with clathrin-coated pits, including clathrin heavy chain and AP-2
(Marsh and McMahon, 1999).
Third, they did not contain internalized transferrin, which is a marker for
the clathrin-derived endocytic system. Finally, the macropinocytic structures
carrying EGFR-CFP into the cell were not inhibited when clathrin-mediated
uptake was blocked by overexpression of AP180, a clathrin adaptor molecule.
Because we did not characterize the fate of EGFR-CFP and Grb2-YFP for periods
after EGF stimulation longer than 60 minutes, it is possible that these
molecules eventually are delivered into the conventional endocytic pathway
leading to lysosomes. Our time-lapse images early after stimulation with EGF,
however, demonstrate that EGFR-CFP and Grb2-YFP at the plasma membrane are
internalized into large structures that do not resemble in size or composition
the endocytic structures derived from clathrincoated pits.
Insight into the role of Grb2 in the nonclathrin uptake pathway followed by
EGFR-CFP and Grb2-YFP was gained from experiments expressing GFP-tagged Grb2
mutants where the structural integrity of the Grb2 SH3 domain was disrupted.
When these mutants were expressed in cells, they translocated normally to the
plasma membrane in response to EGF stimulation and then clustered with
EGFR-CFP within large, endocytic structures. However, these structures did not
subsequently translocate into the interior of the cell, in contrast to what is
observed in wild-type Grb2-expressing cells. Thus, the SH3 domains of Grb2 are
necessary for inward translocation of Grb2- and EGFR-containing endocytic
structures, but not for stimulus-induced Grb2 recruitment to membranes and the
clustering/uptake of EGFR into large endocytic structures. Despite the
inhibition of movement of EGFR-containing endocytic structures by the Grb2 SH3
domain mutants, Tfn was internalized normally with or without EGF stimulation
in the presence of these Grb2 mutations. This finding supports the idea that
the endocytosis machinery for EGFR differs from that used by the TfnR,
consistent with the previous evidence
(Warren et al., 1997;
Warren et al., 1998
).
Flow cytometric analysis measuring avidin inaccessibility showed that, in
the presence of Grb2 SH3 mutations, EGF-induced membrane vesicles could
sequester internalized contents, but the vesicles were unable to detach from
the plasma membrane and move into the cytoplasm. Therefore, an important focus
of future work will be in determining which binding partner(s) of the Grb2 SH3
domain and their downstream signaling pathways are involved in vesicle release
and translocation into the cell center. Dynamin is thought to mediate the
process of pinching off vesicles from the membrane
(Schmid et al., 1998). In
addition, the GTPase activity of dynamin is reported to be enhanced by its
interaction with the Grb2 SH3 domains
(Barylko et al., 1998
;
Gout et al., 1993
;
Herskovits et al., 1993
).
Therefore, disruption of dynamin-Grb2 interactions by mutations in the Grb2
SH3 domains might be predicted to lead to the failure in targeting of dynamin
to the cell periphery, explaining the inhibition of vesicle release.
Unexpectedly, however, dynamin was found to redistribute to the cell periphery
upon EGF stimulation regardless of the presence of the Grb2 SH3 domain mutants
(data not shown). Although it is possible that the redistributed dynamin
GTPase activity was not enhanced sufficiently in the presence of these
mutants, it seems more likely that some other protein binding to the Grb2 SH3
domains is responsible for the release of these vesicles from the plasma
membrane and their ability to translocate inward to the cell center.
In summary, we have examined the dynamics of Grb2 and EGFR fused to GFP spectral variants in single live cells, and have demonstrated that interactions through Grb2 SH3 domains regulate EGFR internalization. We further show that Grb2 is responsible for coupling EGFR-containing membranes with downstream effectors involved in the internalization of these membranes through a macropinocytic pathway. Grb2 has previously been thought to serve solely as an adapter linking receptors on the plasma membrane to downstream signaling pathways. Our results shed light on the additional function of Grb2 as a regulator of activation-induced, clathrin-independent endocytosis.
![]() |
Acknowledgments |
---|
![]() |
Footnotes |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Ando, A., Yonezawa, K., Gout, I., Nakata, T., Ueda, H., Hara, K., Kitamura, Y., Noda, Y., Takenawa, T., Hirokawa, N. et al. (1994). A complex of GRB2-dynamin binds to tyrosine-phosphorylated insulin receptor substrate-1 after insulin treatment. EMBO J. 13,3033 -3038.[Abstract]
Barylko, B., Binns, D., Lin, K. M., Atkinson, M. A., Jameson, D.
M., Yin, H. L. and Albanesi, J. P. (1998). Synergistic
activation of dynamin GTPase by Grb2 and phosphoinositides. J.
Biol. Chem. 273,3791
-3797.
Buday, L. and Downward, J. (1993). Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell 73,611 -620.[Medline]
Buday, L., Khwaja, A., Sipeki, S., Farago, A. and Downward,
J. (1996). Interactions of Cbl with two adapter proteins,
Grb2 and Crk, upon T cell activation. J. Biol. Chem.
271,6159
-6163.
Carter, R. E. and Sorkin, A. (1998).
Endocytosis of functional epidermal growth factor receptor-green fluorescent
protein chimera. J. Biol. Chem.
273,35000
-35007.
Chang, C. P., Kao, J. P., Lazar, C. S., Walsh, B. J., Wells, A.,
Wiley, H. S., Gill, G. N. and Rosenfeld, M. G. (1991).
Ligand-induced internalization and increased cell calcium are mediated via
distinct structural elements in the carboxyl terminus of the epidermal growth
factor receptor. J. Biol. Chem.
266,23467
-23470.
Chang, C. P., Lazar, C. S., Walsh, B. J., Komuro, M., Collawn,
J. F., Kuhn, L. A., Tainer, J. A., Trowbridge, I. S., Farquhar, M. G.,
Rosenfeld, M. G. et al. (1993). Ligand-induced
internalization of the epidermal growth factor receptor is mediated by
multiple endocytic codes analogous to the tyrosine motif found in
constitutively internalized receptors. J. Biol. Chem.
268,19312
-19320.
Chardin, P., Camonis, J. H., Gale, N. W., van Aelst, L., Schlessinger, J., Wigler, M. H. and Bar-Sagi, D. (1993). Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. Science 260,1338 -1343.[Medline]
Clark, S. G., Stern, M. J. and Horvitz, H. R. (1992). C. elegans cellsignalling gene sem-5 encodes a protein with SH2 and SH3 domains. Nature 356,340 -344.[Medline]
Cory, G. O., MacCarthy-Morrogh, L., Banin, S., Gout, I., Brickell, P. M., Levinsky, R. J., Kinnon, C. and Lovering, R. C. (1996). Evidence that the Wiskott-Aldrich syndrome protein may be involved in lymphoid cell signaling pathways. J. Immunol. 157,3791 -3795.[Abstract]
Egan, S. E., Giddings, B. W., Brooks, M. W., Buday, L., Sizeland, A. M. and Weinberg, R. A. (1993). Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363, 45-51.[Medline]
Ellenberg, J., Lippincott-Schwartz, J. and Presley, J. F. (1998). Two-color green fluorescent protein time-lapse imaging. Biotechniques 25,838 -842, 844-846.[Medline]
Ellenberg, J., Lippincott-Schwartz, J. and Presley, J. F. (1999). Dual-colour imaging with GFP variants. Trends Cell Biol. 9,52 -56.[Medline]
Ford, M., Pearse, B., Higgins, M., Vallis, Y., Owen, D., Gibson,
A., Hopkins, C., Evans, P. and McMahon, H. (2001).
Simulataneous binding of PtdIns(4,5)P2 and clathrin by AP180 in the nucleation
of clathrin lattices on membranes. Science
291,1051
-1055.
Gamou, S., Kim, Y. S. and Shimizu, N. (1984). Different responses to EGF in two human carcinoma cell lines, A431 and UCVA-1, possessing high numbers of EGF receptors. Mol. Cell Endocrinol. 37,205 -213.[Medline]
Gout, I., Dhand, R., Hiles, I. D., Fry, M. J., Panayotou, G., Das, P., Truong, O., Totty, N. F., Hsuan, J., Booker, G. W. et al. (1993). The GTPase dynamin binds to and is activated by a subset of SH3 domains. Cell 75,25 -36.[Medline]
Haigler, H. T., McKanna, J. A. and Cohen, S. (1979). Direct visualization of the binding and internalization of a ferritin conjugate of epidermal growth factor in human carcinoma cells A-431. J. Cell Biol. 81,382 -395.[Abstract]
Hanazono, Y., Odai, H., Sasaki, K., Iwamatsu, A., Yazaki, Y. and Hirai, H. (1996). Proto-oncogene products Vav and c-Cbl are involved in the signal transduction through Grb2/Ash in hematopoietic cells. Acta Haematol. 95,236 -242.[Medline]
Herskovits, J. S., Shpetner, H. S., Burgess, C. C. and Vallee, R. B. (1993). Microtubules and Src homology 3 domains stimulate the dynamin GTPase via its C-terminal domain. Proc. Natl. Acad. Sci. USA 90,11468 -11472.[Abstract]
Hu, P., Margolis, B., Skolnik, E. Y., Lammers, R., Ullrich, A. and Schlessinger, J. (1992). Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors. Mol. Cell. Biol. 12,981 -990.[Abstract]
Krupp, M. N., Connolly, D. T. and Lane, M. D. (1982). Synthesis, turnover, and down-regulation of epidermal growth factor receptors in human A431 epidermoid carcinoma requirements. Mol. Biol. Cell 4,715 -727.[Abstract]
Li, N., Batzer, A., Daly, R., Yajnik, V., Skolnik, E., Chardin, P., Bar-Sagi, D., Margolis, B. and Schlessinger, J. (1993). Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature 363, 85-88.[Medline]
Lin, H. C., Barylko, B., Achiriloaie, M. and Albanesi, J. P.
(1997). Phosphatidylinositol (4,5)-bisphosphate-dependent
activation of dynamins I and II lacking the proline/arginine-rich domains.
J. Biol. Chem. 272,25999
-26004.
Lowenstein, E. J., Daly, R. J., Batzer, A. G., Li, W., Margolis, B., Lammers, R., Ullrich, A., Skolnik, E. Y., Bar-Sagi, D. and Schlessinger, J. (1992). The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70,431 -442.[Medline]
Marsh, M. and McMahon, H. T. (1999). The
structural era of endocytosis. Science
285,215
-220.
Meisner, H., Conway, B. R., Hartley, D. and Czech, M. P. (1995). Interactions of Cbl with Grb2 and phosphatidylinositol 3'-kinase in activated Jurkat cells. Mol. Cell. Biol. 15,3571 -3578.[Abstract]
Okabayashi, Y., Kido, Y., Okutani, T., Sugimoto, Y., Sakaguchi,
K. and Kasuga, M. (1994). Tyrosines 1148 and 1173 of
activated human epidermal growth factor receptors are binding sites of Shc in
intact cells. J. Biol. Chem.
269,18674
-18678.
Okutani, T., Okabayashi, Y., Kido, Y., Sugimoto, Y., Sakaguchi,
K., Matuoka, K., Takenawa, T. and Kasuga, M. (1994). Grb2/Ash
binds directly to tyrosines 1068 and 1086 and indirectly to tyrosine 1148 of
activated human epidermal growth factor receptors in intact cells.
J. Biol. Chem. 269,31310
-31314.
Pawson, T. (1995). Protein modules and signalling networks. Nature 373,573 -580.[Medline]
Pomerance, M., Multon, M. C., Parker, F., Venot, C., Blondeau,
J. P., Tocque, B. and Schweighoffer, F. (1998). Grb2
interaction with MEK-kinase 1 is involved in regulation of Jun-kinase
activities in response to epidermal growth factor. J. Biol.
Chem. 273,24301
-24304.
Romero, F., Ramos-Morales, F., Dominguez, A., Rios, R. M.,
Schweighoffer, F., Tocque, B., Pintor-Toro, J. A., Fischer, S. and Tortolero,
M. (1998). Grb2 and its apoptotic isoform Grb3-3 associate
with heterogeneous nuclear ribonucleoprotein C, and these interactions are
modulated by poly(U) RNA. J. Biol. Chem.
273,7776
-7781.
Rozakis-Adcock, M., McGlade, J., Mbamalu, G., Pelicci, G., Daly, R., Li, W., Batzer, A., Thomas, S., Brugge, J., Pelicci, P. G. et al. (1992). Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 360,689 -692.[Medline]
Rozakis-Adcock, M., Fernley, R., Wade, J., Pawson, T. and Bowtell, D. (1993). The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature 363,83 -85.[Medline]
Schmid, S. L., McNiven, M. A. and De Camilli, P. (1998). Dynamin and its partners: a progress report. Curr. Opin. Cell Biol. 10,504 -512.[Medline]
She, H. Y., Rockow, S., Tang, J., Nishimura, R., Skolnik, E. Y., Chen, M., Margolis, B. and Li, W. (1997). Wiskott-Aldrich syndrome protein is associated with the adapter protein Grb2 and the epidermal growth factor receptor in living cells. Mol. Biol. Cell 8,1709 -1721.[Abstract]
Soler, C., Beguinot, L. and Carpenter, G.
(1994). Individual epidermal growth factor receptor
autophosphorylation sites do not stringently define association motifs for
several SH2-containing proteins. J. Biol. Chem.
269,12320
-12324.
Sorkin, A. (1998). Endocytosis and intracellular sorting of receptor tyrosine kinases. Frontiers Biosci. 3,d729 -d738.
Sorkin, A., McClure, M., Huang, F. and Carter, R. (2000). Interaction of EGF receptor and Gb2 in living cells visualized by fluorescence resonance energy transfer (FRET) microscopy. Curr. Biol. 10,1395 -1398.[Medline]
Vidal, M., Montiel, J. L., Cussac, D., Cornille, F., Duchesne,
M., Parker, F., Tocque, B., Roques, B. P. and Garbay, C.
(1998). Differential interactions of the growth factor
receptor-bound protein 2 N-SH3 domain with son of sevenless and dynamin.
Potential role in the Ras-dependent signaling pathway. J. Biol.
Chem. 273,5343
-5348.
Vieira, A. V., Lamaze, C. and Schmid, S. L.
(1996). Control of EGF receptor signaling by clathrin-mediated
endocytosis. Science
274,2086
-2089.
Wang, Z. and Moran, M. F. (1996). Requirement for the adapter protein GRB2 in EGF receptor endocytosis. Science 272,1935 -1939.[Abstract]
Warren, R. A., Green, F. A. and Enns, C. A.
(1997). Saturation of the endocytic pathway for the transferrin
receptor does not affect the endocytosis of the epidermal growth factor
receptor. J. Biol. Chem.
272,2116
-2121.
Warren, R. A., Green, F. A., Stenberg, P. E. and Enns, C. A.
(1998). Distinct saturable pathways for the endocytosis of
different tyrosine motifs. J. Biol. Chem.
273,17056
-17063.
Wells, A., Welsh, J. B., Lazar, C. S., Wiley, H. S., Gill, G. N. and Rosenfeld, M. G. (1990). Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. Science 247,962 -964.[Medline]
Zhu, G., Decker, S. J. and Saltiel, A. R. (1992). Direct analysis of the binding of Src-homology 2 domains of phospholipase C to the activated epidermal growth factor receptor. Proc. Natl. Acad. Sci. USA 89,9559 -9563.[Abstract]